{
  "claim_id": "claim_003",
  "claim": "Recombinant technology leads to a broader immune response that may provide cross-protection, even in a mismatch season.",
  "document": "CDC_Influenza_vaccines",
  "additional_evidence_check": {
    "checked_for_more": true,
    "found_additional": false,
    "additional_count": 0
  },
  "completeness_stats": {
    "existing_evidence": 0,
    "new_evidence_found": 0,
    "total_evidence": 0
  },
  "verified_evidence": [],
  "new_evidence": [],
  "model_used": "gpt-4.1"
}